Innovation1 Biotech Stock Today
| IVBT Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 38
|
Innovation1 Biotech is selling for under 0.001 as of the 22nd of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.001. Innovation1 Biotech has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Innovation1 Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Innovation1 Biotech Inc. operates as a small molecule drug discovery company. The company was founded in 2014 and is based in New York, New York. Innovation1 Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 20.02 M outstanding shares. More on Innovation1 Biotech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Innovation1 OTC Stock Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Innovation1 Biotech [IVBT] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innovation1 Biotech's market, we take the total number of its shares issued and multiply it by Innovation1 Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Innovation1 Biotech conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 20.02 M outstanding shares.
Innovation1 Biotech currently holds about 636.16 K in cash with (3.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Innovation1 Biotech Probability Of Bankruptcy
Ownership AllocationInnovation1 Biotech has a total of 20.02 Million outstanding shares. Innovation1 Biotech retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.66 (percent) of Innovation1 Biotech outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Innovation1 Ownership Details
Innovation1 Stock Against Markets
Picking the right benchmark for Innovation1 Biotech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Innovation1 Biotech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Innovation1 Biotech is critical whether you are bullish or bearish towards Innovation1 Biotech at a given time. Please also check how Innovation1 Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Innovation1 Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.